Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2025-12-26 @ 2:29 AM
Study NCT ID:
NCT07180160
Status:
RECRUITING
Last Update Posted:
2025-11-18
First Post:
2025-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Iparomlimab and Tuvonralimab (QL1706) in Patients With HR-positive, HER2-negative Advanced Breast Cancer
Sponsor:
Wenjin Yin
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-09-25
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-10
First Submit QC Date:
None
Study First Post Date:
2025-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-16
Last Update Post Date:
2025-11-18
Last Update Post Date Type:
ESTIMATED